1975, B.A., Magna Cum Laude, Adelphi University, Garden City, New York: Biology 1979, M.D., University of Louisville School of Medicine, Louisville, Kentucky BOARD CERTIFIED IN GERIATRIC AND ADULT PSYCHIATRY POST GRADUATE TRAINING:
1979-80
Intern in Medicare, Norwalk Hospital, Norwalk, CT
Resident Psychiatry, Yale University School of Medicine, New Haven,CT
Chief Resident, Connecticut Mental Health Center, New Haven, CT
Chief Resident, Community Services, Connecticut Mental Center, Fellow Geriatric Psychiatry, Yale University School of Medicine
Post-Doctoral Fellow, Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine
APPOINTMENTS:
1984-1986
Assistant Clinical Professor of Psychiatry, Yale University School of Medicine
Assistant Professor of Psychiatry and Director, Fellowship in Geriatric Psychiatry, Yale University School of Medicine
Director, Alzheimer’s and Cognitive Disorders Research Unit, Dept. of
Psychiatry, Yale University School of Medicine 1991-1993
Assistant Clinical Professor of Psychiatry, Yale University School of
Medicine 1993-Present Associate Clinical Professor of Psychiatry, Yale University School of Medicine
PROFESSIONAL CERTIFICATE/LICENSURE:
Diplomate, American Board of Psychiatry and Neurology 1985 Added Qualifications in Geriatric Psychiatry, 1991 Connecticut (022695) 1981 DEA (AS 285726) 1981 PROFESSIONAL ACTIVITIES:
Managing Partner, Geriatric & Adult Psychiatry, LLC (1991-present) Medical Director, The Geriatric Psychiatry Alliance, American Association for Geriatric Psychiatry (9/95-1/97) Attending, Consultation Service, Yale New Haven Hospital (1986-1993) Director, Fellowship in Geriatric Psychiatry (1986-1991) Director, Alzheimer’s and Cognitive Disorders Research Unit, Yale University School of Medicine (1987-1991) Medical Director, Alzheimer’s Resource Center of Connecticut, Plantsville, CT (1992-1999) PROFESSIONAL HONORS:
1988- Roncalli Charities of Connecticut, Community Service Award 1997- Outstanding Contribution, American Association for Geriatric Psychiatry OTHER PROFESSIONAL ACTIVITIES:
1983-1990, Board of Directors, Alzheimer’s Disease and Related Disorders Association (ADRDA), South Central Connecticut Chapter 1985-1991, Psychiatry Consultant, Systolic Hypertension in the Elderly Project, Henry Black, M.D., Principal Investigator, Yale School of Medicine
1985-1994, Psychiatric Consultant, Jewish Home for the Elderly, Fairfield,CT
1986-1988, President, Alzheimer’s Disease and Related Disorders Assoc., South Central Connecticut Chapter 1986-1989, Member, Board of Directors, American Assoc. for Geriatric Psychiatry
1990-1991, Treasurer, American Assoc. for Geriatric Psychiatry 1990-Present, President, Alzheimer’s Resource Center, Inc., a non-profit foundation Currently operating a 120 bed Alzheimer’s long-term care center, Southington, CT 1992 - President Elect, American Association for Geriatric Psychiatry 1992-1994, President, American Association for Geriatric Psychiatry TEACHING ACTIVITIES:
1981
Psychopharmacology Update Monthly lectures for PGY II Residents-Program Director (10 hrs)
Psychiatry 101 – Small group session co-leader (1st year medical students) (30 hrs)
1984-present Intensive in Geriatric Psychiatry (3rd year medical students) (21 hrs) 1985-1986
Introduction to Clinical Medicine Physical Examination Preceptor (2nd
year medical students (10 hrs) 1985-1986
Introduction to Clinical Medicine Intensive in Geriatrics (2nd yr. medical
students) (6 hrs) 1986-present Supervision of PGY II, III, IV psychiatry residents, CMHC outpatient service, Consult Service, Yale New Haven Hospital (4hrs/wk) 1988
Faculty preceptor – Yale Medical Student Summer Research Program, 2nd year medical students (48 hrs)
Psychiatry 101 – Lecturer: The Geriatric Patient (1.5 hrs)
Physicians’ Associate Program, Topics in Geriatrics lectures (1st & 2nd yr PA students) (5 hrs)
Elective in Geriatric Psychiatry (PGY 111 & IV Psychiatry residents) (15 hrs)
Initiated and coordinated Journal Club for Psychiatry residents at Yale New Haven Hospital (20 hrs)
Introduction to Clincial Medicine Medical Student Interview Skills (2nd year students) (2 hrs)
Psych 101 – Lecturer: The Geriatric Patient (1.5 hrs)
Psych 101 – Lecturer: The Geriatric Patient (1.5 hrs)
Psych 101 – Lecturer: The Geriatric Patient (1.5 hrs)
MEMBERSHIPS: American Medical Association American Psychiatric Association Connecticut Psychiatry Society Connecticut State Medical Society American Geriatric Society American Association for Geriatric Psychiatry New Haven County Medical Association American Medical Directors Association COMMITTEE APPOINTMENTS:
1980-83 Residency Selection Committee, Department of Psychiatry, Yale University
1983 Inpatient Services Reorganization Committee, Connecticut Mental Health Ctr 1983 Chairman, Management of the Violent Patient Committee, Connecticut Mental Health Ctr. 1983-86 Chairman, Outpatient Services Committee, CT Psychiatric Society 1984-89 Chairman, Professional Advisory Committee, Alzheimers Disease and Related Disorders Assoc., South Central Connecticut Chapter 1984-85 Chairman, Program Committee, Connecticut Psychiatric Society, New Haven/Middlesex Chapter 1984-87 Deputy Chairman, Public Affairs Committee, CT Psychiatric Society 1985 Planning Committee, Conference of the CT Assoc. for Mental Health &
1985-87 Councilor, New Haven Chapter, Connecticut Psychiatric Society 1986-89 Member, Admissions Committee, Physician’s Associates Program, Yale University School of Medicine 1986-87 Graduate Education Committee, Department of Psychiatry, Yale University School of Medicine
1987-Present Chairman, Geriatric Psychiatry Committee. Connecticut Psychiatric Society, 1989-91 Annual Symposium and Meeting, Program Planning Committee, American Association for Geriatric Psychiatry 1989-1991 Education and Fellowship Committee-AAGP 1990-1992 Finance Committee-AAGP 1995-1997 Chairman, Industry Relations Council, American Association for Geriatric Psychiatry 1998-2004 Yale New Haven Hospital, IPA Board Member 2004- Present Yale Community Medical Group Board Member GRANTS AND CONTRACTS AWARDED:
A.H. Robins Company, “Randomized Clinical Trial of Guanfacine to Improve Memory in Age-Associated Memory Impairment,” April 1, 1988-June 15, 1989, $226,000, Principal Investigator Miles, Inc., “Randomized Clinical Trial Nimodipine to Prevent or Retard Deterioration in Primary Degenerative Dementia,” January 1, 1989-December 30, 1992, $181, 940, Principal Investigator Jewish Home for the Elderly, Fellowship in Geriatric Psychiatry, July 1, 1989-June 30, 1990, $56, 265 Jewish Home for the Elderly, Psychiatric Consultation Contract, July 1,1990-June 30, 1991; $28,200 Bristol Meyers-Squibb-Nefazadone, Safety & Efficacy in Geriatric Depressed Patients, March 1992-December 1993 Parke-Davis: Treatment IND for Cognex, January 1992-December 1993 Burroughs Wellcome-Wellbutrin SR, 1993 Eisai Pharmaceuticals – E2020, November 1993-April 1997 Bristol Meyers-Squibb – Buspar in Dementia Patients, February 1994-January 1997 Janssen Pharmaceuticals – Risperidone, 1995-July 1997 Eli Lilly & Co. – Olanzepine in Dementia – November 1996 – present Eisai Pharmaceutical – E2020 in Nursing Home Residents – July 1996 – present
Eisai Pharmaceutical – E2020 Dementia with Vascular Etiology – July 1997 Eli Lilly & Co. – Fluoxetine in Depressed Nursing Home Residents – September 1997- present Pfizer – Sertraline in Depressed, Geriatric Outpatients, September 1997 – present Bayer – Metrifonate in Alzheimer’s Disease Patients, September 1997 – present Janssen Pharmaceuticals – Risperidone vs. Olanzepine in Elderly Schizophrenia, October 1997 BIBLIOGRAPHY: Original Articles:
1. John Kennedy, Walter Deberdt, Siegal, AP. Olanzapine does not enhance
cognitive in non-agitated and non-psychotic patients with mild to moderate Alzheimer’s dementia. International Journal of Geriatric Psychiarty 2005; 20:1020-1027.
2. Siegal, AP, Astrachan, BM, Levine, ML: Re-evaluating the work of a community
mental health center: the care of chronic patients. Hospital Community Psychiatry 1984; 35:1129-1132.
3. Siegal, AP, Astrachan, BM, Levine, MS. Service Utilization: A Re-evaluation of
the Work in Caring for the Chronically Mentally Ill in a Community Mental Health Center Proceedings of the 8th Annual MSIS National Users Group Conference, Nathan S. Kline Institute, 25-34, 1984.
4. Siegal, AP, Levine MS. Indirect Services in the Care of the Chronically Mentally
Ill and Administrative Implications for MSI. Proceedings of the 9th Annual MSIS National Users Group, Nathan S. Kline Institute, 189-193, 1985.
5. Imperiale, TF, Siegal, AP, Crede, WB, Kames, EA. Pre-admission screening of
Medicare patients: The clinical impact of reimbursement disapprovals. JAMA 1988; 259 (23) 3418-2421.
6. Rohrbaugh, R, Siegal AP, Giller, E. Irritability as a symptoms of depression in
the elderly. J Am Geriatric Soc. 1988; 36 (8): 736-738
7. Rohrbaugh R, Siegal AP: Reversible Anorexia and Rapid Weight Loss Associated
with Neuroleptic Administration in Alzheimer’s Disease. Journal of Geriatric Psychiatry and Neurology, 2:45-47, 1989.
8. Inouye, SK, Van Dyck, CH, Alessi, CA, Bulken S, Siegal, AP, Horowitz RI,:
Clarifying Confusion: A New Screening Method for Delirium, The Confusion Assessment Method, Annals of Internal Medicine, 1990; 113:941-948.
9. Lachs, MS, Becker, M, Siegal, AP, Miller, RL, Tinetti ME: Delusions and
Behavioral Disturbances in Cognitively Impaired Elderly Persons, Jn Amer Geriatrics Soc. 40: 768-773, 1992
10. Neistein, S, Siegal, AP: Agitation, Wandering, Pacing, Restlessness and
Repetitive Mannerisms, International Psycho Geriatrics, 1996, 8, Supplement 3, 339-403.
11. Lachs, MS, Williams, CS, O’Brien, S, Hurst, L, Kossack, A, Siegal, AP, Tinetti,
ME: ED Use by Older Victims of Family Violence, Annuals of Emergency Medicine, 30:4, 1997
12. Duncan, BA, Siegal, AP : Early Diagnosis and Management of Alzheimer’s
Disease, J Clinical Psychiatry 1991; 59 (suppl 9): 15-21.
13. Grossberg, G, Jackson, JM, Tariot, P, Fraser, M, Jacobs L, Carroll, R, Smith, D,
Sherman D, Torgerson D, and Siegal, AP: The Annals of Long-Term Care, Managing Elderly Patients with Acute Behavioral Changes in the Long-Term Care Setting, May 1999.
14. Tangalos, EG, MaGuire GA, Siegal, AP, DeVane CL: Behavioral Manifestations
of Psychosis and Depression in Long-Term Care Settings: From Clinical Trials to Bedside Therapy, May 2001.
15. Siegal, AP: Documentation in the Long-Term Care Setting: July 2002
16. John Kennedy, Walter Deberdt, Alan P. Siegal, : Olazapine does not enhance
cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia: International Journal of Geriatric Psychiatry: 2005; 22:1-8
1. Siegal, AP, Siegal, RS, Forget Me Not, Caring for and Coping with Your Aging
2. Siegal, AP, Jackson, JM, Geriatric Psychiatry Practice Management Handbook,
Book Reviews, Letters, Book Chapters:
1. Dementia: A Practical Guide to Alzheimer’s Disease and Related Disorders by
Leonard L. Heston. Am J Psychiatry 1985; 143 (3): 382-383
2. A Guide to Alzheimer’s Disease for Families, Spouses and Friends by Barry
Reisberg. Am J Psychiatry 1985; 142 (3) : 382-383
3. Alzheimer’s Disease: A Guide for Families by Leonore S. Powell and Kathie
Courtice. Am J Psychiatry 1985; 142 (3): 181-183
4. Siegal, AP. Medicare and Alzheimer’s Disease (letter). Hosp. Comm. Pyschiatry
5. Alzheimer’s Disease: The Standard Reference by Barry Reisberg. Am J
6. The Social Transformation of American Medicine by Paul Starr. Am J Psychiatry
PRESENTATIONS/LECTURES:
1. February 24, 2001 – American Association for Geriatric Psychiatry 14th Annual
Meeting, San Francisco, CA: Behavioral Manifestations of Psychosis and Depression in Long-Term Care Settings: From Clinical Trials to Bedside Therapy
2. March 15, 2001 – American Medical Directors Association 2001 Annual
Symposium, Atlanta, GA (chair): Comparing and Contrasting the Atypical Antipsychotics: A Data-Driven Focus on Differentiation.
3. January 9, 2002 – Stony Brook University, Stony Brook , New York:
4. January 14, 2002- Windom Hospital, Windom CT: Advances in Atypical
5. February 6, 2002 – Teleconference: Agitation in Dementia.
6. March 10.2002 –American Geriatrics Society Annual Meeting - Washington ,DC
:Advances in Atypical Antipsychotic and Psychotropic therapy.
7. March 15, 2002 – Boston, MA: Co-chair Long Term Care meeing
8. April 3, 2002 – Hewitt Foundation, Trumbull, CT: Delirium in Elderly.
9. April 9, 2002- Raleigh, NC: Treatment of Aggression and Agitation in Elderly
Patients.Annual Meeting AMDA North/South Carolina
10. April 10, 2002 – Westborough, MA: Managing Depression in Long Term Care
11. April 17, 2002- Grand Rounds – Dept of Psychiatry - Stony Brook, NY: Update,
12. April 23, 2002 – Agency on Aging, Fairfield University, and Bridgeport, CT:
13. May 2, 2002 – Cornell Westchester, Grand Rounds - White plains, NY:
14. May 15, 2002- Dedham, Ma: Agitation in Dementia: Finding Clarity in the
15. May 23, 2002 - Philadelphia, PA: Treating Aggression in Patients with Dementia.
16. June 10,2002 – Teleconference: Managing the Agitated Alzheimer’s Dementia
17. June 26, 2002 – Continuing Medical Education, Geriatric Congress - Anaheim,
CA: Recognizing and Identifying Agitation related Dementia.
18. August 23, 2002 – New York, NY: Alzheimer’s Disease Advisory Council.
19. September 24, 2002 – Parker Institute, New Hyde Park, NY: Geriatric
20. December 3, 2002 - Tampa, FL: Pharmerica Annual Meeting: Depression in Long
21. January 24, 2003 – Dallas, TX: “Bringing AD Management to the Frontline of LTC”
22. March 14, 2003 – Boston, Mass: Pfizer – Northeast region Neuroscience
23. March 19,2003 – New York, NY: DRIVE Medical Consulting – Zyprexa Long
Term Care Regional Customer Feedback forum
24. March 27, 2003 – Providence, RI: Novartis – “Are All Cholinesterase Inhibitors
25. April 8, 2003 – Stony Brook, NY: Pfizer – “Geriatric Neurophysiology Issues in
26. April 9, 2003 – Stony Brook, NY: Pfizer – “Managing the Behavioral
27. April 11, 2003 – Westbrook, CT: Yale – “Cognitive Assessment and Differential
28. May 21, 2003 – Pittsburgh, PA: Grand Rounds UPMC Hospital
29. June 1,2003 – Cambridge, MA: APNA – “Are All Cholinesterase Inhibitors the
30. July 11-13,2003 – Tampa, FL: AstraZeneca – 2003 Seroquel LTC National
31. September 4-7, 2003 – Boca Raton, FL: Bristol-Myers Squibb – VISION Abilify
32. September 12-13, 2003- Baltimore, MD: Lilly – 2003 Treatment Guidelines
33. September 20, 2003 – Philadelphia, PA: CME inc – “Alzheimer’s Disease:
Practical Approaches to Detect, Diagnosis, and Achieve Optimal Therapeutic Outcomes”
34. October 11, 2003 – Atlanta, GA: CME Inc – “Alzheimer’s Disease: Practical
Approaches to Detect, Diagnosis, and Achieve Optimal Therapeutic Outcomes”
35. October 25, 2003 – Seattle, WA: CME inc. – “Alzheimer’s Disease: Practical
Approaches to Detect, Diagnosis, and Achieve Optimal Therapeutic Outcomes”
36. November 1, 2003 – Cleveland, OH: CME inc. – “Alzheimer’s Disease: Practical
Approaches to Detect, Diagnosis, and Achieve Optimal Therapeutic Outcomes”
37. November 15, 2003 – Long Island, NY: CME inc. – “Alzheimer’s Disease:
Practical Approaches to Detect, Diagnosis, and Achieve Optimal Therapeutic Outcomes”
38. December 6, 2003 – Miami, FL: CME inc – “Alzhemier’s Disease: Practical
Approaches to Detect, Diagnosis, and Achieve Optimal Therapeutic Outcomes”
39. April 9, 2004 – Teleconference : Lilly – “Bipolar Mania: An Overview of
40. April 9, 2004 – Seymour, CT: Forest Pharmaceuticals -“Namenda: Changing the
Treatment Paradigm in Alzheimer’s Disease”
41. April 13, 2004 – Teleconference sponsored by Forest – “Anxiety and
42. April 27, 2004 – Westport, CT : Forest -“Namenda: Changing the Treatment
43. May 12, 2004 -Teleconference : Lilly – “Bipolar Mania: An Overview of
44. May 17-18,2004 – Las Vegas, NV: American Geriatrics Society Meeting:
“Remission vs Response, Painful Physical Symptoms, and Depression”
45. May 25, 2004 – Bridgeport, CT :Forest / St Vincents Hospital: -“Namenda:
Changing the Treatment Paradigm in Alzheimer’s Disease”
46. June 9, 2004 – West Springfield, MA: Forest -“Namenda: Changing the
Treatment Paradigm in Alzheimer’s Disease”
47. July 16, 2004 – Philadelphia, PA: AstraZeneca – “2004 Long Term Care National
48. January 11, 2005 – Teleconference: Forest “ Treating depression and Anxiety in
49. January 19, 2005 – Teleconference: Abbott - “Novel Approaches to the Treatment
50. February 23, 2005 – Wallingford, CT: Forest -“Namenda: Changing the
Treatment Paradigm in Alzheimer’s Disease”
51. March 2-3, 2005 – San Diego, CA: Pfizer 2 day lecture tour “The Importance of
Diagnosing and How to Diagnose in a Short Time”
52. March 29, 2005 – Norwich, CT : Forest -“Namenda: Changing the Treatment
53. March 30, 2005 – Avon, CT: Forest – “One Effective Therapy for Depression and
54. April 19-21, 2005 – Las Vegas, NV: Pfizer 3 day talk tour, Aricept & Zoloft
55. April 27, 2005 – Westport, CT: Forest -“Namenda: Changing the Treatment
56. May 18, 2005- New Haven, CT: “ Alzheimer’s Disease and Dementia”
57. June 7, 2005 – Teleconference: Nemenda Advisory Board member.
58. June 17, 2005 – West Haven, CT: Forest -“Namenda: Changing the Treatment
59. June 23, 2005 – Teleconference : Forest, Lexapro “ One Effective Therapy for
Depression and Anxiety in long Term Care”
60. July 9, 2005 – Savahana GA: Forest “ Differential Diagnosis of Major Depression
61. July 2005 - “Developing Best Practices Meeting” Forest/Omnicare Talk Series:
62. August 2005 - “Developing Best Practices Meeting” Forest/Omnicare Talk
Series: Austin, TX; Indianapolis, IN; St Louis, MO
63. August 9-12, 2005 – Minneapolis and Kansas City, MO 4 day talk tour: Lilly;
“Clinical Considerations: Treating a Broad Range of Symptoms in Depressed Patients (Psych)”
64. September 27, 2005 – Omaha , NB: Forest/Omnicare “Developing Best
65. November 2005 - “Developing Best Practices Meeting” Forest/Omnicare Talk
66. September 7, 2005 – Williston Park, NY: Lilly “Clinical Considerations: Treating
a Broad Range of Symptoms in Depressed Patients (Psych)”
BIOGRAPHICAL SKETCH
ALAN P. SIEGAL - D.O.B. 4/1/53 Associate Clinical Professor Department of Psychiatry Yale University School of Medicine Managing Partner Geriatric & Adult Psychiatry, LLC 60 Washington Avenue #203 Hamden, CT 06518 Telephone: (203) 288-0414 EDUCATION: B.A., 1975 – Adelphi University, Garden City, NY M.D., 1979 – University of Louisville School of Medicine, Louisville, KY
Entre 1932 y 1946, el dramaturgo español Miguel Mihura (1905-1977) intenta irrumpir en el mundo del teatro madrileño con obras vanguardistas como Tres sombreros de Copa (1932). Frente al sucesivo fracaso económico de este tipo de pieza experimental, sin embargo, se ve forzado a producir comedias de índole comercial que le permitan el fácil acceso a los escenarios, el éxito y la renta
NOTICE: All slip opinions and orders are subject to formalrevision and are superseded by the advance sheets and boundvolumes of the Official Reports. If you find a typographicalerror or other formal error, please notify the Reporter ofDecisions, Supreme Judicial Court, John Adams Courthouse,Pemberton Square, Suite 2500, Boston, MA 02108-1750; (617) 557-1030; [email protected]. Se